Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

NCT01329276 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Symbicort® forte Turbohaler®

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]